Roche and Zealand Pharma ink a $5.3 billion deal to co-develop and co-commercialize an obesity drug, positioning Zealand alongside major weight-loss companies.
Cisco, NIKE, IBM, Johnson & Johnson, Home Depot Ranked Among Dobermans of Dow, a refined investment strategy focused on high-quality companies with attractive valuations.
Roche and Zealand Pharma ink a $5.3 billion deal to co-develop and co-commercialize an obesity drug, positioning Zealand alongside major weight-loss companies.
Cisco, NIKE, IBM, Johnson & Johnson, Home Depot Ranked Among Dobermans of Dow, a refined investment strategy focused on high-quality companies with attractive valuations.